The Policlinico of Milan also known as Ospedale Maggiore di Milano or Ca' Granda Ospedale Maggiore Policlinico, is one of the oldest hospitals in Italy, founded by Duke Francesco Sforza in 1456. Today it is a modern hospital with 900 beds, with wards for adults, pregnant women and children.

There are 900 beds in Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.

During the past decade, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico conducted 356 clinical trials. In the 10-year time frame, 356 clinical trials started and 83 clinical trials were completed, i.e. on average, 23.3% percent of trials that started reached the finish line to date. In the past 5 years, 197 clinical trials started and 64 clinical trials were completed. i.e. 32.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico" #1 sponsor was "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico" with 56 trials, followed by "Policlinico Hospital" with 33 trials sponsored, "Celgene" with 22 trials sponsored, "Janssen Research & Development, LLC" with 17 trials sponsored and "Gilead Sciences" with 17 trials sponsored. Other sponsors include 333 different institutions and companies that sponsored additional 177 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico" #1 collaborator was "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico" with 13 trials as a collaborator, "Eli Lilly and Company" with 7 trials as a collaborator, "Takeda Development Center Americas, Inc." with 7 trials as a collaborator, "University of Milan" with 5 trials as a collaborator and "Baxalta Innovations GmbH, now part of Shire" with 4 trials as a collaborator. Other collaborators include 275 different institutions and companies that were collaborators in the rest 199 trials.

According to Clinical.Site data, the most researched conditions in "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico" are "Cystic Fibrosis" (15 trials), "Hemophilia A" (11 trials), "Crohn Disease" (9 trials), "Endometriosis" (8 trials) and "COVID-19" (7 trials). Many other conditions were trialed in "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico" in a lesser frequency.

Most popular intervention types in "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico" are "Drug" (273 trials), "Other" (65 trials), "Procedure" (47 trials), "Biological" (36 trials) and "Device" (27 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (81 trials), "IVA" (8 trials), "Rituximab" (7 trials), "JNJ-73763989" (6 trials) and "Baricitinib" (5 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico" are 436 trials for "All" genders, 23 trials for "Female" genders and 21 trials for "Male" genders.

Currently, there are NaN active trials in "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico". undefined are not yet recruiting, 107 are recruiting, 66 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 203 completed trials in Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 2 suspended trials, and 50 terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 23 "Phase 1" clinical trials were conducted, 115 "Phase 2" clinical trials and 177 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 57 trials that are defined as “Not Applicable".

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico has several departments that took part in Clinical trials: "Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia" - 9 trials, "Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore" - 4 trials, "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Unità Operativa Complessa di Neurologia" - 4 trials, "Ospedale Maggiore di Milano, Divisione di Ematologia" - 3 trials, "Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico; UOSD Malattie Neurodegenerative" - 3 trials, "Celiac Disease Center, Fondazione IRCCS Cà Granda" - 2 trials, "Ospedale Maggiore Policlinico; Unità Operativa Complessa di Allergologia e Immunologia Clinica" - 2 trials, "Ospedale Maggiore Policlinico; U.O.C. di Oncologia Medica" - 2 trials, "Ospedale Maggiore Policlinico; Iii Divisione Medicina Generale" - 2 trials, "Ospedale Maggiore Policlinico, Divisione Di Cardiologia" - 2 trials